Guides › NMN (nicotinamide mononucleotide)
NMN (nicotinamide mononucleotide) in Australia: evidence and prices
TL;DR
NMN is a precursor of NAD+ that is popular in longevity circles. A 2026 meta-analysis of 15 short trials (14 days to 24 weeks) found it was well tolerated but showed no clear broad metabolic benefits. A 2025 meta-analysis found no significant effect on muscle mass or function in older adults. Long-term data are limited. Check the ARTG and ask your GP before use.
Safety and metabolic outcomes
A 2026 systematic review and meta-analysis (15 randomised trials, doses 250–2,000 mg/day, 14 days to 24 weeks) found NMN did not increase adverse events or liver enzymes, and found no significant effects on weight, glucose, HbA1c, lipids or systolic blood pressure. The authors call for larger, longer trials. [1]
Muscle and ageing
A 2025 meta-analysis in adults with a mean age over 60 found NMN had no significant effects on muscle mass, grip strength or gait speed. [2]
Australian status
We have not yet verified NMN's regulatory status in Australia. Check the TGA's ARTG before buying, and be cautious of imported products.
Prices in Australia
Price check pending. We couldn't verify current Australian retailer prices yet, so none are shown.
FAQ
Does NMN reverse ageing?
There is no good human evidence that it does. Trials so far are short and small.
Is NMN legal in Australia?
We haven't verified this yet. Check the TGA ARTG or ask a pharmacist.
Sources
- Yang W et al. Safety and metabolism-related outcomes of oral NMN in adults: systematic review and meta-analysis (Nutrients, 2026; PubMed 42514320)
- Prokopidis K et al. NMN and NR on skeletal muscle mass and function: systematic review and meta-analysis (J Cachexia Sarcopenia Muscle, 2025; PubMed 40275690)
Sources checked 15 Oct 2026. Pending human review before publication.